APA (7th ed.) Citation

Arlegui, H., Bollaerts, K., Salvo, F., Bauchau, V., Nachbaur, G., Bégaud, B., & Praet, N. (2020). Benefit–Risk Assessment of Vaccines. Part I: A Systematic Review to Identify and Describe Studies About Quantitative Benefit–Risk Models Applied to Vaccines. Drug Safety, 43(11), 1089. https://doi.org/10.1007/s40264-020-00984-7

Chicago Style (17th ed.) Citation

Arlegui, Hugo, Kaatje Bollaerts, Francesco Salvo, Vincent Bauchau, Gaëlle Nachbaur, Bernard Bégaud, and Nicolas Praet. "Benefit–Risk Assessment of Vaccines. Part I: A Systematic Review to Identify and Describe Studies About Quantitative Benefit–Risk Models Applied to Vaccines." Drug Safety 43, no. 11 (2020): 1089. https://doi.org/10.1007/s40264-020-00984-7.

MLA (9th ed.) Citation

Arlegui, Hugo, et al. "Benefit–Risk Assessment of Vaccines. Part I: A Systematic Review to Identify and Describe Studies About Quantitative Benefit–Risk Models Applied to Vaccines." Drug Safety, vol. 43, no. 11, 2020, p. 1089, https://doi.org/10.1007/s40264-020-00984-7.